Title Comprehensive evaluation of variability in nicotine metabolism andCYP 2 A 6 polymorphic alleles in four ethnic populations

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Isoflavones Inhibit Nicotine C‐Oxidation Catalyzed by Human CYP2A6

  2006cited by this paper
• Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

  2005cited by this paper
• CHARACTERIZATION OF NOVEL CYP2A6 POLYMORPHIC ALLELES (CYP2A6*18 AND CYP2A6*19) THAT AFFECT ENZYMATIC ACTIVITY

  2005cited by this paper
• Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk.

  2005cited by this paper
• A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.

  2005cited by this paper
• Three haplotypes associated with CYP2A6 phenotypes in Caucasians

  2005cited by this paper
• The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.

  2004cited by this paper
• Novel human CYP2A6 alleles confound gene deletion analysis

  2004cited by this paper
• A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo

  2004cited by this paper
• Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6).

  2004cited by this paper
• Oral contraceptives induce CYP2A6 activity and accelerate nicotine metabolism

  2004influential reference
• A nicotine C‐oxidase gene (CYP2A6) polymorphism important for promoter activity

  2004cited by this paper
• Interindividual variability of coumarin 7-hydroxylation in a Turkish population

  2004cited by this paper
• Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro

  2003cited by this paper
• Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

  2003cited by this paper
• A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

  2002cited by this paper
• Medical therapy for ulcerative colitis.

  2002cited by this paper
• The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease

  2002cited by this paper
• Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.

  2002cited by this paper
• Gender Differences in Tobacco Smoking: Higher Relative Exposure to Smoke Than Nicotine in Women

  2002cited by this paper
• Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity

  2002cited by this paper
• Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.

  2002cited by this paper
• Nicotine and nicotinic receptors; relevance to Parkinson's disease.

  2002cited by this paper
• Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.

  2002cited by this paper
• Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women.

  2002cited by this paper
• Characterization of nicotine and cotinine N-glucuronidations in human liver microsomes.

  2002cited by this paper
• Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans

  2001cited by this paper
• CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity*

  2001cited by this paper
• Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity.

  2001cited by this paper
• A novel single nucleotide polymorphism altering stability and activity of CYP2a6.

  2001cited by this paper
• Nicotine metabolism and CYP2A6 allele frequencies in Koreans.

  2001cited by this paper
• Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography.

  2000cited by this paper
• Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

  2000cited by this paper
• Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.

  1999cited by this paper
• Ethnic differences in N-glucuronidation of nicotine and cotinine.

  1999cited by this paper
• A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.

  1999cited by this paper
• Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

  1999cited by this paper
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

  1999cited by this paper
• Nicotine metabolism and intake in black and white smokers.

  1998cited by this paper
• Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase

  1998cited by this paper
• Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.

  1996influential reference
• Role of human cytochrome P4502A6 in C-oxidation of nicotine.

  1996cited by this paper
• Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers.

  1996cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

  1996cited by this paper
• Menthol cigarette smoking in African Americans and whites

  1995cited by this paper
• Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight.

  1994cited by this paper
• Cigarette smoking, nicotine addiction, and its pharmacologic treatment.

  1993cited by this paper
• Race and sex differences in lung cancer risk associated with cigarette smoking.

  1993cited by this paper
• Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

  1992cited by this paper
• The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

  1990cited by this paper
• Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study.

  1990cited by this paper
• Determination of nicotine and cotinine in human serum and urine: an interlaboratory study.

  1987cited by this paper

• Determining Optimal Cutoffs for Exhaled Carbon Monoxide and Salivary Cotinine to Identify Smokers among Korean Americans in a Smoking Cessation Clinical Trial

  2021cites this paper
• Reply to 'Safety profile of capecitabine as maintenance treatment after XELOX or FOLFOX in metastatic colorectal cancer patients' by C. Cremolini et al.

  2016cites this paper